X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (10) 10
humans (10) 10
middle aged (9) 9
male (8) 8
rheumatology (7) 7
index medicus (6) 6
adult (5) 5
aged (5) 5
internal medicine (5) 5
arthritis (4) 4
care and treatment (4) 4
double-blind (4) 4
hyaluronic acid (4) 4
knee osteoarthritis (4) 4
life sciences (4) 4
osteoarthritis (4) 4
tumor necrosis factor-alpha - antagonists & inhibitors (4) 4
viscosupplementation (4) 4
antirheumatic agents - adverse effects (3) 3
arthritis, rheumatoid - drug therapy (3) 3
human health and pathology (3) 3
intra-articular injection (3) 3
knee (3) 3
mannitol (3) 3
orthopedics (3) 3
pain (3) 3
psoriasis (3) 3
rheumatoid arthritis (3) 3
rhumatology and musculoskeletal system (3) 3
rituximab (3) 3
treatment outcome (3) 3
[ sdv.mhep.rsoa ] life sciences [q-bio]/human health and pathology/rhumatology and musculoskeletal system (2) 2
adalimumab (2) 2
analgesics (2) 2
anti-tnf (2) 2
antibodies, monoclonal - adverse effects (2) 2
antirheumatic agents - administration & dosage (2) 2
antirheumatic agents - therapeutic use (2) 2
aortite (2) 2
aortitis (2) 2
aortitis - diagnosis (2) 2
biomarkers (2) 2
clinical trials (2) 2
controlled trial (2) 2
drug therapy (2) 2
etanercept (2) 2
follow-up (2) 2
hip (2) 2
hyaluronic acid - administration & dosage (2) 2
immunoglobulin g - adverse effects (2) 2
infliximab (2) 2
injections, intra-articular (2) 2
magnetic resonance imaging (2) 2
management (2) 2
medicine, general & internal (2) 2
necrosis factor therapy (2) 2
original research (2) 2
osteoarthritis, knee - drug therapy (2) 2
outcomes (2) 2
positron-emission tomography (2) 2
prospective studies (2) 2
recurrence (2) 2
retrospective studies (2) 2
rheumatoid-arthritis (2) 2
severity of illness index (2) 2
task-force (2) 2
tocilizumab (2) 2
treatment (2) 2
tumor necrosis factor (2) 2
viscosupplements - administration & dosage (2) 2
175591-09-0 (1) 1
175591-23-8 (1) 1
[ scco.neur ] cognitive science/neuroscience (1) 1
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
[scco.neur]cognitive science/neuroscience (1) 1
[sdv.mhep.rsoa]life sciences [q-bio]/human health and pathology/rhumatology and musculoskeletal system (1) 1
abatacept (1) 1
abscesses (1) 1
acceptable symptom state (1) 1
adalimumab - administration & dosage (1) 1
adalimumab - adverse effects (1) 1
adalimumab plus methotrexate (1) 1
adverse drug effects (1) 1
aged, 80 and over (1) 1
agent (1) 1
alopecia (1) 1
alopécie (1) 1
analysis (1) 1
aneurysm (1) 1
aneurysms (1) 1
ankylosing spondylitis (1) 1
ankylosing-spondylitis (1) 1
anti tnf alpha (1) 1
anti-inflammatory agents (1) 1
anti-inflammatory agents - adverse effects (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, monoclonal (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2016, Volume 75, Issue 1, pp. 59 - 67
Journal Article
JAMA, ISSN 0098-7484, 09/2016, Volume 316, Issue 11, pp. 1172 - 1180
IMPORTANCE: One-third of patients with rheumatoid arthritis show inadequate response to tumor necrosis factor α (TNF-α) inhibitors; little guidance on choosing... 
AGENT | MEDICINE, GENERAL & INTERNAL | MULTICENTER | ADALIMUMAB | ANTITUMOR-NECROSIS-FACTOR | INADEQUATE RESPONSE | RITUXIMAB | DOUBLE-BLIND | OUTCOMES | INHIBITOR | ABATACEPT | Care and treatment | Research | Tumor necrosis factor | Rheumatoid arthritis | Clinical trials | Tumor necrosis factor-TNF | TNF inhibitors
Journal Article
Knee, The, ISSN 0968-0160, 2016, Volume 23, Issue 5, pp. 842 - 848
Abstract Background To compare both safety and efficacy of a novel intra-articular viscosupplement made of intermediate molecular weight (MW) hyaluronic acid... 
Orthopedics | Controlled trial | Intra-articular injection | Knee osteoarthritis | Hyaluronic acid | Viscosupplementation | Mannitol | Osteoarthritis | Care and treatment
Journal Article
Journal Article
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 01/2016, Volume 9
Objectives The objective of this study is to obtain pilot data from daily practice conditions of a viscosupplement made of a cross-linked high-molecular-weight... 
Journal Article
Joint Bone Spine, ISSN 1297-319X, 2008, Volume 75, Issue 3, pp. 315 - 318
Abstract The widespread use of TNFα antagonists in recent years has led to the recognition of paradoxical adverse effects, defined as the onset or exacerbation... 
Internal Medicine | Rheumatology | Psoriasis | Adverse drug effects | TNFα antagonists | RHEUMATOID-ARTHRITIS | PUSTULOSIS | adverse drug effects | psoriasis | RHEUMATOLOGY | NECROSIS FACTOR THERAPY | TNF alpha antagonists
Journal Article
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, ISSN 1179-5441, 09/2016, Volume 2016, Issue 9, pp. 175 - 179
Objectives The objective of this study is to obtain pilot data from daily practice conditions of a viscosupplement made of a cross-linked high-molecular-weight... 
Intra-articular injection | Knee osteoarthritis | Hyaluronic acid | Viscosupplementation | Mannitol
Journal Article
Journal of Pain Research, ISSN 1178-7090, 2012, Volume 5, pp. 121 - 138
This open-label, phase 3b study (ClinicalTrials.gov Identifier: NCT00983073) evaluated the effectiveness, and tolerability of tapentadol for severe, chronic... 
Opioid | Osteoarthritis | Tapentadol | Chronic pain | Knee pain | Care and treatment | Pain | Drug therapy | Methods | Knee | Arthritis | Analgesics | chronic pain | tapentadol | osteoarthritis | opioid
Journal Article
Revue du Rhumatisme (Edition Francaise), ISSN 1169-8330, 05/2012, Volume 79, Issue 3, pp. 281 - 282
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 05/2012, Volume 79, Issue 3, pp. 281 - 282
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 03/2014, Volume 81, Issue 2, pp. 192 - 193
Journal Article